Cargando…
Real-world Data: MCL2 Protocol Demonstrates Excellent Treatment Results Among Patients With Mantle Cell Lymphoma Not Fulfilling the Original Trial Inclusion Criteria
Autores principales: | Harmanen, Minna, Klaavuniemi, Tuula, Sorigue, Marc, Khan, Madiha, Prusila, Roosa, Kari, Esa, Alanne, Erika, Rajamäki, Aino, Sunela, Kaisa, Jukkola, Arja, Jantunen, Esa, Sancho, Juan-Manuel, Ketola, Sanna, Kuitunen, Hanne, Selander, Tuomas, Rönkä, Aino, Kuittinen, Outi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10489256/ https://www.ncbi.nlm.nih.gov/pubmed/37693119 http://dx.doi.org/10.1097/HS9.0000000000000954 |
Ejemplares similares
-
Mortality among patients with low‐grade follicular lymphoma: A binational retrospective analysis
por: Rajamäki, Aino, et al.
Publicado: (2022) -
FDG‐PET/CT‐guided rebiopsy may find clinically unsuspicious transformation of follicular lymphoma
por: Rajamäki, Aino, et al.
Publicado: (2022) -
Primary central nervous system lymphoma high incidence and poor survival in Finnish population-based analysis
por: Puhakka, Inka, et al.
Publicado: (2022) -
CD34(+) Cell Mobilization, Autograft Cellular Composition and Outcome in Mantle Cell Lymphoma Patients
por: Turunen, Antti Samuli, et al.
Publicado: (2023) -
Previous radiotherapy improves treatment responses and causes a trend toward longer time to progression among patients with immune checkpoint inhibitor-related adverse events
por: Jokimäki, Anna, et al.
Publicado: (2023)